Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements US$ 24.97 Min. order: 1 piece ★★★★★ 4.5 (118 reviews) Sold : Login>>
Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports US$ 21.94 Min. order: 1 piece ★★★★★ 4.6 (206 reviews) Sold : Login>>
Biology of Incretins: GLP-1 and GIP US$ 26.56 Min. order: 1 piece ★★★★★ 4.1 (153 reviews) Sold : Login>>
Focus on Glucagon-like Peptide-1 Target: Drugs Approved or Designed to Treat Obesity US$ 27.44 Min. order: 1 piece ★★★★★ 4.2 (211 reviews) Sold : Login>>
Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic US$ 23.24 Min. order: 1 piece ★★★★★ 4.7 (11 reviews) Sold : Login>>
Eli Lilly's GIP/GLP-1 Dual Agonist Tirzepatide: Lowering Blood Sugar, Weight, And Cardiovascular Risk! - Industry news - News US$ 20.12 Min. order: 1 piece ★★★★★ 4.3 (100 reviews) Sold : Login>>